Cancer Clinical Trials

Bone

  • CALGB 70604 - A Randomized, Phase III Study of Standard Dosing versus Longer Dosing Interval of Zoledronic Acid in Metastatic Cancer - OverviewPDF document

Brain

  • RTOG 0825 - Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma (Closed to Enrollment) - OverviewPDF document

Breast

  • CINJ 040406-4862 - Effect of DNA Variations on Breast Cancer Risk and Recurrence - OverviewPDF document

  • ECOG 5103 - A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide Followed By Paclitaxel with Bevacizumab or Placebo in Patients with Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer (Step 1 Closed to Enrollment, Effective February 28, 2011) - OverviewPDF document

  • NSABP B-39 RTOG 0413 - Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I or II Breast Cancer - OverviewPDF document

  • NSABP B-47 - A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer - OverviewPDF document

  • Wyeth 3144A2-3004-WW - A Randomized Double-blind Placebo-Controlled Trial of Neratinib (HKI-272) After Trastuzumab in Women With Early-Stage HER-2/neu Overexpressed/Amplified Breast Cancer (Closed to Enrollment) - OverviewPDF document

Gastrointestinal

  • Amgen 20080259 - A Phase 3, Randomized, Double-blind, Placebo-controlled Pegfilgrastim Administered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab and Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI) (Closed to Enrollment) - OverviewPDF document

  • Bayer 73-4506_14387 - A Randomized, Double-Blind, Placebo-Controlled Phase III Study of Regorafenib Plus BSC Versus Placebo Plus BSC in Patients with Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Therapy (Closed to Enrollment) - OverviewPDF document

  • CALGB-SWOG C80405 - A Phase III Trial of Irinotecan/5-FU/Leucovorin or Oxaliplatin/5-FU/Leucovorin with Bevacizumab, or Cetuximab (C225), or with Combination of Bevacizumab and Cetuximab for Patients with Untreated Metastatic Adenocarcinoma of the Colon or Rectum - OverviewPDF document

  • CINJ 130901 - Health Behaviors among Individuals Diagnosed with Colorectal Cancer - OverviewPDF document

Genitourinary

  • RTOG 0815 - A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy with or without Short-Term Androgen Deprivation Therapy for Patients with Intermediate-Risk Prostate Cancer - OverviewPDF document

Hematologic

  • ECOG 2905 - A Randomized Phase III Trial Comparing the Frequency of Major Erythroid Response (MER) to Treatment with Lenalidomide (Revlimid®) Alone and in Combination with Epoetin Alfa (Procrit®) in Subjects with Low- Or Intermediate-1 Risk MDS and Symptomatic Anemia (Re-Opened to Enrollment, Effective February 4, 2011) - OverviewPDF document

Lung

  • ECOG 1505 - A Phase III Randomized Trial of Adjuvant Chemotherapy with or without Bevacizumab For Patients with Completely Resected Stage IB-IIIA Non-Small Cell Lung Cancer - OverviewPDF document

  • ImClone IMCL CP12-0917 - An Open-label, Multicenter, Randomized, Phase 2 Study of a Recombinant Human Anti-VEGFR-2 Monoclonal Antibody, IMC-1121B in Combination with Platinum-based Chemotherapy versus Platinum-based Chemotherapy Alone as First-line Treatment of Patients with Recurrent or Advanced Non-small Cell Lung Cancer(NSCLC) - OverviewPDF document

Ovary

  • GOG 0262-ACRIN 6695 - A Randomized Phase III Trial of Every-3-Weeks Paclitaxel Versus Dose Dense Weekly Paclitaxel in Combination With Carboplatin With or Without Concurrent and Consolidation Bevacizumab in the Treatment of Primary Stage II, III or IV Epithelial Ovarian, Peritoneal or Fallopian Tube Cancer - OverviewPDF document

© Copyright 2012, Meridian Health, Inc. | 732-840-2200

Ocean Medical Center | 425 Jack Martin Boulevard, Brick, NJ 08724